Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.

Jadhav A, Ferreira RS, Klumpp C, Mott BT, Austin CP, Inglese J, Thomas CJ, Maloney DJ, Shoichet BK, Simeonov A.

J Med Chem. 2010 Jan 14;53(1):37-51. doi: 10.1021/jm901070c.

2.

In vitro behavior of multifunctionalized fullerene-warfarin conjugates.

Zacchigna M, Klumpp C, Prato M, Bianco A.

J Nanosci Nanotechnol. 2009 Oct;9(10):6210-21.

PMID:
19908517
3.

A robotic platform for quantitative high-throughput screening.

Michael S, Auld D, Klumpp C, Jadhav A, Zheng W, Thorne N, Austin CP, Inglese J, Simeonov A.

Assay Drug Dev Technol. 2008 Oct;6(5):637-57. doi: 10.1089/adt.2008.150. Review.

4.

Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor.

Titus S, Neumann S, Zheng W, Southall N, Michael S, Klumpp C, Yasgar A, Shinn P, Thomas CJ, Inglese J, Gershengorn MC, Austin CP.

J Biomol Screen. 2008 Feb;13(2):120-7. doi: 10.1177/1087057107313786. Epub 2008 Jan 23.

5.

Dual-fluorophore quantitative high-throughput screen for inhibitors of BRCT-phosphoprotein interaction.

Simeonov A, Yasgar A, Jadhav A, Lokesh GL, Klumpp C, Michael S, Austin CP, Natarajan A, Inglese J.

Anal Biochem. 2008 Apr 1;375(1):60-70. Epub 2007 Dec 5.

6.

Evaluation of micro-parallel liquid chromatography as a method for HTS-coupled actives verification.

Simeonov A, Yasgar A, Klumpp C, Zheng W, Shafqat N, Oppermann U, Austin CP, Inglese J.

Assay Drug Dev Technol. 2007 Dec;5(6):815-24.

PMID:
18078381
7.

Multifunctionalised cationic fullerene adducts for gene transfer: design, synthesis and DNA complexation.

Klumpp C, Lacerda L, Chaloin O, Da Ros T, Kostarelos K, Prato M, Bianco A.

Chem Commun (Camb). 2007 Sep 28;(36):3762-4. Epub 2007 Jul 5.

PMID:
17851620
8.

[60]fullerene-pyrrolidine-N-oxides.

Brough P, Klumpp C, Bianco A, Campidelli S, Prato M.

J Org Chem. 2006 Mar 3;71(5):2014-20.

PMID:
16496988
9.

Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.

Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3357-62. Epub 2006 Feb 21.

10.

Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics.

Klumpp C, Kostarelos K, Prato M, Bianco A.

Biochim Biophys Acta. 2006 Mar;1758(3):404-12. Epub 2005 Nov 9. Review.

11.

Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes.

Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand JP, Gennaro R, Prato M, Bianco A.

Angew Chem Int Ed Engl. 2005 Oct 7;44(39):6358-62. No abstract available.

PMID:
16138384
12.
13.

Clinical efficacy and compatibility of allogeneic avital tissue transplants sterilized with a peracetic acid/ethanol mixture.

Pruss A, Perka C, Degenhardt P, Maronna U, Büttner-Janz K, Paul B, Müller K, Klumpp C, Bruck JC, Von Versen R.

Cell Tissue Bank. 2002;3(4):235-43.

PMID:
15256872
14.

Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program.

Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B.

J Pediatr Hematol Oncol. 1996 Feb;18(1):36-41.

PMID:
8556368

Supplemental Content

Loading ...
Support Center